Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2002 1
2003 2
2004 3
2005 1
2006 1
2008 1
2009 6
2010 4
2011 4
2012 3
2013 3
2014 2
2015 1
2016 8
2017 7
2018 11
2019 15
2020 14
2021 15
2022 5
2023 7
2024 10
2025 19
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.
Ortiz-Maldonado V, Liang EC, Huang JJ, Jeon Y, Hirayama AV, Kimble EL, Portuguese AJ, Khouderchah C, Braathen K, Torkelson A, Kirchmeier D, Shadman M, Maloney DG, Riddell SR, Turtle CJ, Gauthier J. Ortiz-Maldonado V, et al. Among authors: turtle cj. Haematologica. 2026 Jul 2. doi: 10.3324/haematol.2025.300321. Online ahead of print. Haematologica. 2026. PMID: 42389828 Free article.
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.
Ahmed N, Ali A, Kim S, Oloyede T, Bye M, Gowda L, Kamble RT, Mirza AS, Nadiminti KV, Pophali PA, Rodriguez-Bonilla C, Sieg A, Strouse C, Abid MB, Afrough A, Aljurf M, Beitinjaneh AM, Chhabra S, Choe M, Hilal T, Iqbal M, Jain T, Kharfan-Dabaja MA, Modi D, Orti G, Pawarode A, Rao U, Riedell PA, Saad A, Seo S, Balari AS, Wagner JL, Wudhikarn K, Turtle CJ, Phillips CL, Pasquini MC, Ahmed S, Ganguly S, Moskop A. Ahmed N, et al. Among authors: turtle cj. Transplant Cell Ther. 2026 Jun 24:S2666-6367(26)00510-5. doi: 10.1016/j.jtct.2026.06.035. Online ahead of print. Transplant Cell Ther. 2026. PMID: 42341926 Free article.
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival.
Kaur G, Logue J, Brazauskas R, Oloyede T, Abid MB, Ahmed S, Aljurf M, Banerjee R, Bashey A, Beitinjaneh AM, Callander NS, Castillo P, Dholaria B, Goldsmith SR, Hashmi S, Kharfan-Dabaja MA, Liu H, Mian H, Nishihori T, Rejeski K, Saad A, Slade MJ, Turtle CJ, Vogl DT, Williams KM, Wirk B, Pasquini MC, Moskop A, Akhtar OS, Hansen DK, Janakiram M. Kaur G, et al. Among authors: turtle cj. Transplant Cell Ther. 2026 Jun 16:S2666-6367(26)00490-2. doi: 10.1016/j.jtct.2026.06.021. Online ahead of print. Transplant Cell Ther. 2026. PMID: 42302965 Free article.
Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma.
Al-Juhaishi T, Ahn KW, Chen T, Patel KK, Patel J, Herrera AF, Turtle CJ, Rizzo JD, Khimani F, Awan FT, Gibran-Nunes F, Ahmed G, Baird J, Lekakis LJ, Shadman M, Shafey M, Reidell PA, Merryman RW, Hamadani M, Ahmed S. Al-Juhaishi T, et al. Among authors: turtle cj. Transplant Cell Ther. 2026 May 21:S2666-6367(26)00419-7. doi: 10.1016/j.jtct.2026.05.030. Online ahead of print. Transplant Cell Ther. 2026. PMID: 42173253 Free PMC article.
Erratum: Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration.
Li Y, Qiao Y, Gao F, Gauthier J, Zhang QE, Voutsinas J, Leisenring W, Gooley T, Summers C, Hirayama A, Turtle CJ, Gardner R, Zee J, Wu QV. Li Y, et al. Among authors: turtle cj. JCO Clin Cancer Inform. 2026 Apr;10(2):e2600072. doi: 10.1200/CCI-26-00072. Epub 2026 Apr 20. JCO Clin Cancer Inform. 2026. PMID: 42007735 No abstract available.
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response.
Ozog S, Krantz EM, Tindbaek K, Munoz J, Liu WL, Chalal C, Pernikoff S, Yahya K, Stevens-Ayers T, Dasgupta S, Cowan AJ, Green DJ, Gauthier J, Till BG, Gardner RA, Shadman M, Bleakley M, Boeckh M, Boonyaratanakornkit J, Turtle CJ, Hill JA. Ozog S, et al. Among authors: turtle cj. Nat Commun. 2026 Apr 7;17(1):4924. doi: 10.1038/s41467-026-71473-1. Nat Commun. 2026. PMID: 41942445 Free PMC article.
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas.
Mirza AS, Hosing C, Foss F, Kim S, Moskop A, Oloyede T, Abid MB, Afrough A, Ahmed S, Badar T, Barba P, Bhatt VR, Brown VI, Dahiya S, Deol A, Epperla N, Ganguly S, Grover NS, Hashmi H, Hashmi S, Hematti P, Hildebrandt GC, Hill JM Jr, Hossain NM, Ibrahim U, Johnson PC, Kharfan-Dabaja MA, Krem MM, Lekakis LJ, Maziarz RT, Murthy HS, Riedell PA, Salas MQ, Shouse G, Strouse C, Thakar MS, Turtle CJ, Woolfrey A, Wudhikarn K, Yared JA, Pasquini MC, Gowda L. Mirza AS, et al. Among authors: turtle cj. Blood Neoplasia. 2025 Nov 25;3(2):100187. doi: 10.1016/j.bneo.2025.100187. eCollection 2026 May. Blood Neoplasia. 2025. PMID: 41867486 Free PMC article.
140 results